Foresite Capital Management V, LLC
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), Foresite Capital Management V, LLC reported 6 stock positions worth $87.6 million. Its top holding was Alumis (ALMS) at 40.5% of the portfolio, followed by CG Oncology (CGON, 24.0%) and Disc Medicine (IRON, 16.9%). Compared with Q4 2024, it opened 1 new position, sold out of 1, added to 1 and reduced 1. The biggest buy was CG Oncology (CGON, shares +24%) and the biggest sale Hims & Hers Health (HIMS, shares −71%).
- Most Recent 13F
- Q2 2026
- Location
- WEST HOLLYWOOD, CA
- CIK
- 0001792206
- Portfolio Value
- $87.6M (Q1 2025)
- SEC Filing
- 0001104659-25-049396 ↗ filed May 15, 2025
Holdings Value
Holdings 6 stocks · $87.6M
| ALMS Alumis Inc. | 40.50% | 5,779,348 | $35.5M | No change |
| CGON CG Oncology Inc. | 24.01% | 859,050 | $21.0M | Add +24.0% |
| IRON Disc Medicine Inc. | 16.94% | 299,069 | $14.8M | No change |
| HIMS Hims & Hers Health Inc. | 9.21% | 273,151 | $8.1M | Reduce -70.9% |
| LYEL Lyell Immunopharma Inc. | 4.99% | 8,133,047 | $4.4M | No change |
| MAZE Maze Therapeutics Inc. | 4.34% | 345,191 | $3.8M | New |
Portfolio Sells Q4 2024 → Q1 2025
Portfolio Buys Q4 2024 → Q1 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $362.2M | ALMS, CGON, IRON, HIMS, PHVS |
| Q1 2026 | 9 | $271.0M | ALMS, CGON, IRON, HIMS, EIKN |
| Q4 2025 | 7 | $164.4M | ALMS, CGON, IRON, NTRA, LYEL |
| Q3 2025 | 6 | $108.7M | CGON, ALMS, IRON, HIMS, LYEL |
| Q2 2025 | 6 | $80.7M | CGON, ALMS, IRON, HIMS, MAZE |
| Q1 2025 | 6 | $87.6M | ALMS, CGON, IRON, HIMS, LYEL |
| Q4 2024 | 6 | $120.2M | ALMS, HIMS, CGON, IRON, CGEM |
| Q3 2024 | 5 | $143.9M | ALMS, HIMS, CGON, IRON, CGEM |
| Q2 2024 | 5 | $156.6M | ALMS, HIMS, CGON, IRON, CGEM |
| Q1 2024 | 5 | $106.5M | HIMS, CGON, IRON, KNTE, 23ANDME HOLDING CO |